The oral combination of xanomeline and trospium effectively treats schizophrenia without unwanted side effects.
Regulatory
Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.
Posted inNew Drugs, Oncology, Regulatory
Ojemda: Novel Treatment for Low-grade Glioma
Tovorafenib represents a novel standard of care for the most prevalent central nervous system neoplasm affecting children.
Posted inIn the Pipeline, Infections, New Drugs, Regulatory
Shingrix: Excellent Vaccine Against Shingles
Shingrix for robust and long-lasting prevention of herpes zoster and postherpetic neuralgia in all adults.
Posted inInfections, New Drugs, Regulatory
mResvia, Arexvy, Abrysvo: Top Quality RSV Vaccines
It’s time to bury respiratory syncytial virus in the abyss of immunization fire.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Wynayre/Wynfidra: Brand New Drug for COPD Maintenance Therapy
Ensifentrine is a medication with a novel mechanism of action for the maintenance treatment of chronic obstructive pulmonary disease.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Pemgarda: For COVID-19 Protection Instead of Vaccines
Pemivibart every three months. For those who cannot receive the COVID-19 vaccine.
Posted inNew Drugs, Oncology, Regulatory
Datroway/Datverzo: Groundbreaking New Way to Treat Lung Cancer
Datopotamab deruxtecan for the treatment of unresectable NSCLC after failure of first-line therapy.